• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids Phenylpropanoic acids
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids

Introduction to 3-4-(Difluoromethoxy)phenylpropanoic Acid (CAS No. 1000932-18-2)

3-4-(Difluoromethoxy)phenylpropanoic Acid, identified by its Chemical Abstracts Service (CAS) number 1000932-18-2, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the class of phenylpropanoic acids, which are widely studied for their diverse biological activities and potential therapeutic applications. The presence of a difluoromethoxy substituent in the aromatic ring introduces unique electronic and steric properties, making this molecule a valuable scaffold for drug discovery and development.

The structural features of 3-4-(Difluoromethoxy)phenylpropanoic Acid contribute to its remarkable chemical reactivity and biological efficacy. The difluoromethoxy group enhances the lipophilicity and metabolic stability of the molecule, which are critical factors in drug design. Additionally, the phenylpropanoic acid moiety is known to interact with various biological targets, including enzymes and receptors, thereby modulating physiological processes. These characteristics have positioned this compound as a promising candidate for further investigation in medicinal chemistry.

In recent years, there has been a growing interest in exploring the pharmacological potential of 3-4-(Difluoromethoxy)phenylpropanoic Acid. Studies have demonstrated its role as an intermediate in synthesizing novel bioactive molecules with therapeutic implications. For instance, derivatives of this compound have shown promise in inhibiting inflammatory pathways and modulating neurotransmitter systems. The difluoromethoxy substituent plays a pivotal role in enhancing the binding affinity and selectivity of these derivatives towards their target proteins.

One of the most compelling aspects of 3-4-(Difluoromethoxy)phenylpropanoic Acid is its versatility in chemical modifications. Researchers have leveraged its scaffold to develop compounds with enhanced pharmacokinetic profiles and reduced toxicity. The ability to introduce various functional groups while maintaining the core structure allows for the creation of a diverse library of analogs with tailored properties. This flexibility has been instrumental in optimizing drug candidates for clinical trials.

The synthesis of 3-4-(Difluoromethoxy)phenylpropanoic Acid involves multi-step organic reactions that highlight its synthetic accessibility. Advanced techniques such as palladium-catalyzed cross-coupling reactions have been employed to construct the desired aromatic ring system efficiently. The incorporation of the difluoromethoxy group requires careful control over reaction conditions to ensure high yield and purity. These synthetic methodologies underscore the compound's feasibility for large-scale production, which is essential for industrial applications.

From a medicinal chemistry perspective, 3-4-(Difluoromethoxy)phenylpropanoic Acid exemplifies how structural modifications can significantly influence biological activity. The interplay between electronic effects and steric hindrance, mediated by the difluoromethoxy group, dictates its interaction with biological targets. This understanding has guided the design of next-generation compounds that exhibit improved efficacy and reduced side effects. Such advancements are crucial for addressing unmet medical needs and improving patient outcomes.

The pharmacological profile of 3-4-(Difluoromethoxy)phenylpropanoic Acid has been further elucidated through preclinical studies. These investigations have revealed its potential in treating various conditions, including neurological disorders and chronic inflammatory diseases. The compound's ability to modulate key signaling pathways has sparked interest among researchers seeking novel therapeutic strategies. Moreover, its favorable pharmacokinetic properties make it an attractive candidate for further development into a clinical drug.

In conclusion, 3-4-(Difluoromethoxy)phenylpropanoic Acid (CAS No. 1000932-18-2) represents a significant advancement in pharmaceutical research due to its unique structural features and biological activities. The presence of the difluoromethoxy substituent enhances its chemical reactivity and therapeutic potential, making it a valuable scaffold for drug discovery. As research continues to uncover new applications for this compound, it is poised to play an increasingly important role in developing innovative treatments for human diseases.

• 886499-74-7(3-4-(Trifluoromethoxy)phenylpropanoic Acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)